Publications

2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

AuthID
P-00W-DKW

Author(s)

Bedke, J

Albiges, L

Capitanio, U

Giles, RH

Hora, M

Lam, TB

Ljungberg, B

Marconi, L

Klatte, T

Volpe, A

Abu-Ghanem, Y

Dabestani, S

Fernandez-Pello, S

Hofmann, F

Kuusk, T

Tahbaz, R

Powles, T

Bex, A

Document Type

Article

Year published

2022

Published

in EUROPEAN UROLOGY, ISSN: 0302-2838

Volume: 81, Issue: 2, Pages: 134-137 (4)

Indexing

Wos^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.eururo.2021.11.022

Pubmed: 34920897

Wos: WOS:000768798400012

Source Identifiers

ISSN: 0302-2838

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

Useful Links

Get Help

Federated Authentication (Click on the image)

2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

Useful Links

Get Help